Structure Therapeutics, Inc. (GPCR)
50.75
-2.75
(-5.14%)
USD |
NASDAQ |
Apr 17, 16:00
50.75
0.00 (0.00%)
After-Hours: 20:00
Structure Therapeutics SG&A Expense (Quarterly) : 17.65M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Viking Therapeutics, Inc. | 11.28M |
| Novo Nordisk A/S | 2.718B |
| Revolution Medicines, Inc. | 66.68M |
| Kymera Therapeutics, Inc. | 16.94M |